Asafetida, Echinacea Angustifolia, Calcium Sulfide, Potassium Dichromate, Luffa Operculata Whole, Silicon Dioxide, Sinusitisinum
Generic Name: asafetida, echinacea angustifolia, calcium sulfide, potassium dichromate, luffa operculata whole, silicon dioxide, sinusitisinum
Brand Names:
Sinus Relief
Purpose: For the temporary relief of sinus pain and inflammation.
Overview
Purpose: For the temporary relief of sinus pain and inflammation.
Uses
Indications & Usage: Turn tube upside down, twist cap to break seal & release pellets. Using clear cap, place 3 pellets to dissolve under your tongue 3 times a day or as needed. Take apart from food or drinks. To preserve purity avoid touching pellets with fingers.
Dosage
Dosage & Administration: Turn tube upside down, twist cap to break seal & release pellets. Using clear cap, place 3 pellets to dissolve under your tongue 3 times a day or as needed. Take apart from food or drinks. To preserve purity avoid touching pellets with fingers.
Warnings
Warnings: If symptoms persist or worsen, or if pregnant or nursing, consult a doctor. Keep out of reach of children. Do not use if cap seal is broken or missing.
Frequently Asked Questions
What is Asafetida, Echinacea Angustifolia, Calcium Sulfide, Potassium Dichromate, Luffa Operculata Whole, Silicon Dioxide, Sinusitisinum used for?▼
Indications & Usage: Turn tube upside down, twist cap to break seal & release pellets. Using clear cap, place 3 pellets to dissolve under your tongue 3 times a day or as needed. Take apart from food or drinks. To preserve purity avoid touching pellets with fingers.
What are the important warnings for Asafetida, Echinacea Angustifolia, Calcium Sulfide, Potassium Dichromate, Luffa Operculata Whole, Silicon Dioxide, Sinusitisinum?▼
Warnings: If symptoms persist or worsen, or if pregnant or nursing, consult a doctor. Keep out of reach of children. Do not use if cap seal is broken or missing.
Related Medications
Idecabtagene Vicleucel
idecabtagene vicleucel
11 DESCRIPTION ABECMA is a BCMA-directed genetically modified autologous T cell immunotherapy product consisting of a patient's own T cells that are harvested and genetically modified ex vivo through transduction with an anti-BCMA02 chimeric antigen receptor (CAR) lentiviral vector (LVV). Autologous T cells transduced with the anti-BCMA02 CAR LVV express the anti-BCMA CAR on the T cell surface.
Rg3
rg3
Dosage form: POWDER. Active ingredients: GINSENOSIDE RG3 (1 g/g). Category: BULK INGREDIENT.
Tocilizumab
tocilizumab
Interleukin-6 Receptor Antagonist [EPC]
11 DESCRIPTION Tocilizumab-anoh is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1κ (gamma 1, kappa) subclass with a typical H 2 L 2 polypeptide structure. Each light chain and heavy chain consists of 214 and 448 amino acids, respectively. The four polypeptide chains are linked intra- and inter-molecularly by disulfide bonds. Tocilizumab-anoh has a molecular weight of approximately 148 kDa.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.